XML 34 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Cash flows from operating activities:    
Net loss $ (629) $ (485)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Amortization of intangible assets 386 398
Impairment of intangible asset 281  
Depreciation 464 312
Other amortization 90 175
Stock-based compensation 155 187
Contingent earnout liability adjustment (313)  
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable and unbilled receivables 833 (191)
Prepaid expenses and other assets (209) (308)
Accounts payable and accrued liabilities (745) (327)
Deferred revenue (134) 277
Other liabilities (139) (18)
Total adjustments 669 505
Net cash provided by operating activities 40 20
Cash flows from investing activities:    
Equipment and improvements (580) (213)
Acquisitions, net of cash acquired (33)  
Software development capitalization costs (14)  
Contingent acquisition payments (261) (413)
Net cash used in investing activities (888) (626)
Cash flows from financing activities:    
Proceeds from sale of common stock, net of issuance costs   857
Proceeds from exercise of employee stock options 20 121
Borrowings from bank line of credit 1,875 4,450
Payments on bank line of credit (1,849) (4,625)
Payments on acquired debt (120)  
Payments on subordinated promissory notes (83) (42)
Principal payments on capital leases (135) (82)
Net cash (used in)/provided by financing activities (292) 679
Effect of exchange rate changes on cash and cash equivalents (36) 7
Net (decrease)/increase in cash and cash equivalents (1,176) 80
Cash and cash equivalents at beginning of period 2,528 3,045
Cash and cash equivalents at end of period 1,352 3,125
Cash paid for:    
Interest 130 110
Income taxes 34 27
Non cash activities:    
Equipment purchased under capital leases 104 573
Equipment and other assets included in accounts payable 237 50
Accrued contingent consideration (earnouts) 600  
Common stock issued in connection with acquisition $ 150